A pilot clinical study suggests that E6 is an appropriate biomarker for diagnosis of cervical pre-cancer and cancer in a novel oncoprotein-based rapid diagnostic assay for cervical pre-cancer and cancer. Presented at: International Papillomavirus Conference 2009, May 8, 2009; Malmo, Sweden.
Author(s): Schweizer J, Berard-Bergery M, Bisht A, et al
Corporate author(s): PATH, Arbor Vita Corporation, Johns Hopkins Bloomberg School of Public Health
Publication date: May 2009
405 KB PDF
Hard copies are not available.
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
Related regions: Global
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA